Overview

Long-term Trial on Growth Hormone Deficiency in Adults (GHDA)

Status:
Completed
Trial end date:
2006-09-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Japan. This protocol describes an extension trial to supply hGH to subjects who wish continuous treatment after the long-term Phase 3 trial (GHLiquid-1519) until hGH products have been approved for GHDA in Japan.
Phase:
Phase 3
Details
Lead Sponsor:
Novo Nordisk A/S